DE60322228D1 - Schnell zerfallende tablette - Google Patents

Schnell zerfallende tablette

Info

Publication number
DE60322228D1
DE60322228D1 DE60322228T DE60322228T DE60322228D1 DE 60322228 D1 DE60322228 D1 DE 60322228D1 DE 60322228 T DE60322228 T DE 60322228T DE 60322228 T DE60322228 T DE 60322228T DE 60322228 D1 DE60322228 D1 DE 60322228D1
Authority
DE
Germany
Prior art keywords
tablets
crumping
tablet
fast
years
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322228T
Other languages
English (en)
Inventor
Vesna Skulj
Judita Sirca
Osel Maja Jenko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lek Pharmaceuticals dd
Original Assignee
Lek Pharmaceuticals dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals dd filed Critical Lek Pharmaceuticals dd
Application granted granted Critical
Publication of DE60322228D1 publication Critical patent/DE60322228D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE60322228T 2002-06-21 2003-06-20 Schnell zerfallende tablette Expired - Lifetime DE60322228D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200200160A SI21221A (sl) 2002-06-21 2002-06-21 Hitro razpadljive tablete
PCT/EP2003/006528 WO2004000281A1 (en) 2002-06-21 2003-06-20 Rapidly disintegrating tablet

Publications (1)

Publication Number Publication Date
DE60322228D1 true DE60322228D1 (de) 2008-08-28

Family

ID=29778203

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322228T Expired - Lifetime DE60322228D1 (de) 2002-06-21 2003-06-20 Schnell zerfallende tablette

Country Status (9)

Country Link
US (2) US20060115528A1 (de)
EP (1) EP1534245B1 (de)
AT (1) ATE401060T1 (de)
AU (1) AU2003249856A1 (de)
DE (1) DE60322228D1 (de)
EA (1) EA012324B1 (de)
PL (1) PL206248B1 (de)
SI (2) SI21221A (de)
WO (1) WO2004000281A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
RU2391115C2 (ru) * 2004-12-13 2010-06-10 МакНЕЙЛ-ППС, ИНК. Композиции и способы стабилизации активных фармацевтических ингредиентов
WO2007058397A1 (en) * 2005-11-17 2007-05-24 Gl Pharmtech Corp. A dispersible tablet comprising the mixture of amoxicillin and clavulanic acid or its salts and processes for preparing the same
TW200815020A (en) * 2006-06-15 2008-04-01 Serenex Inc Stabilized tetracycline compositions
WO2013106601A1 (en) * 2012-01-10 2013-07-18 Michael Spector Pediatric oral suspension formulations of amoxicillin and clavulanate potassium and method for using same
WO2013173808A2 (en) * 2012-05-17 2013-11-21 Michael Spector Methods for use of lower dose compositions of amoxicillin and clavulanate potassium and devices for use
WO2013173803A2 (en) * 2012-05-17 2013-11-21 Michael Spector Formulations of amoxicillin and clavulanate potassium and methods for using same
US9254261B2 (en) 2014-03-03 2016-02-09 Sandoz Ag Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid
US20160008310A1 (en) 2014-07-11 2016-01-14 Azanta A/S Misoprostol dispersible tablet
NZ727876A (en) 2014-07-11 2018-05-25 Azanta Danmark As Misoprostol dispersible tablet
CN104173601B (zh) * 2014-08-20 2017-11-07 黑龙江天翼药业有限公司 板蓝大青片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
RU2159618C2 (ru) * 1995-06-22 2000-11-27 Акцо Нобель Н.В. Прессованные таблетки дезогестрела, изготовленные способом сухого гранулирования
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
US5985823A (en) * 1997-06-09 1999-11-16 Ambi Inc. Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US6368625B1 (en) * 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
CA2393231A1 (en) * 1999-12-06 2001-06-07 Edward Mendell Co., Inc. Pharmaceutical superdisintegrant

Also Published As

Publication number Publication date
EA012324B1 (ru) 2009-08-28
ATE401060T1 (de) 2008-08-15
PL206248B1 (pl) 2010-07-30
WO2004000281A1 (en) 2003-12-31
US20060115528A1 (en) 2006-06-01
EA200500031A1 (ru) 2005-08-25
AU2003249856A1 (en) 2004-01-06
SI1534245T1 (sl) 2009-02-28
PL373034A1 (en) 2005-08-08
EP1534245A1 (de) 2005-06-01
US20120028949A1 (en) 2012-02-02
SI21221A (sl) 2003-12-31
EP1534245B1 (de) 2008-07-16

Similar Documents

Publication Publication Date Title
ZA200501559B (en) Probiotics for gut neuromuscular functions
EP2248519A3 (de) Nichtmukoadhäsive Filmdosierungsformen
FI20011851A (fi) Fluoksetiinia tai sen happoadditiosuolaa sisältävä dispergoituva tabletti
TR200002541T2 (tr) Topiramatın farmasötik bilişimi
EA200400881A1 (ru) Азаарилпиперазины
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
HUP0301452A2 (hu) Fotokemoterápiás szert és mukoadhéziós szert tartalmazó gyógyszerkészítmény és alkalmazása
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
GB2431346C (en) A combination composition comprising paracetamol and ibuprofen
HUP0301349A2 (hu) IL-11-tartalmú készítmények
DE60322228D1 (de) Schnell zerfallende tablette
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
BR0312728A (pt) Formulação em tablete dispersìvel e processo para sua preparação
ATE243504T1 (de) Cefadroxilmonohydrat tablettenformulierung
FR2717081B1 (fr) Rétropeptides, anticorps dirigés contre ces derniers, et leurs utilisations pour la vaccination et le diagnostic in vitro.
HUP0102159A2 (hu) Készítmény savtúltengés kezelésére
ATE451340T1 (de) Deuterierte catecholaminderivate sowie diese verbindungen enthaltende arzneimittel
DE60004204D1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
HK1075654A1 (en) Hyperforin derivatives, the use thereof and formulations containing them
MD2211G2 (ro) Remediu pentru tratamentul afecţiunilor periodonţiului
ATE253555T1 (de) Vitamin d-analogen und ihre pharmazeutische verwendung
AU2003247704A1 (en) Methods and compositions for diagnosing hepatocellular carcinoma
DE50304524D1 (de) Arzneimittel enthaltend substituierte 2,5-diaminomethyl-1h-pyrrole
UA40749A (uk) Препарат для лікування затримки посліду і ендометритів у корів - "ендосан"
RU2002127274A (ru) Применение препарата ветом-7048 впервые в качестве лекарственного препарата при лечении атрофии мозга, гидроцефалии мозга

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN